Global and Region Orexin Receptor Type 2 Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Orexin Receptor Type 2 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Orexin Receptor Type 2market, defines the market attractiveness level of Orexin Receptor Type 2 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Orexin Receptor Type 2 industry, describes the types of Orexin Receptor Type 2 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Orexin Receptor Type 2 market and the development prospects and opportunities of Orexin Receptor Type 2 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Orexin Receptor Type 2 market in Chapter 13.

    By Player:

    • OptiNose US Inc

    • Johnson & Johnson

    • Heptares Therapeutics Ltd

    • Actelion Pharmaceuticals Ltd

    • Yangtze River Pharmaceutical Group

    • Merck & Co Inc

    • Idorsia Ltd

    • Evotec AG

    • Eisai Co Ltd

    By Type:

    • HTL-6641

    • MK-8133

    • Lemborexant

    • OPN-021

    • YNT-185

    • Others

    By End-User:

    • Insomnia

    • Narcolepsy

    • Sleep Disorders

    • Major Depressive Disorder

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Orexin Receptor Type 2 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Orexin Receptor Type 2 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Orexin Receptor Type 2 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Orexin Receptor Type 2 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Orexin Receptor Type 2 Market Analysis and Outlook to 2022

    • 7.1 Global Orexin Receptor Type 2 Consumption (2017-2022)

    • 7.2 United States Orexin Receptor Type 2 Consumption (2017-2022)

    • 7.3 Europe Orexin Receptor Type 2 Consumption (2017-2022)

    • 7.4 China Orexin Receptor Type 2 Consumption (2017-2022)

    • 7.5 Japan Orexin Receptor Type 2 Consumption (2017-2022)

    • 7.6 India Orexin Receptor Type 2 Consumption (2017-2022)

    • 7.7 South Korea Orexin Receptor Type 2 Consumption (2017-2022)

    8 Region and Country-wise Orexin Receptor Type 2 Market Analysis and Outlook to 2028

    • 8.1 Global Orexin Receptor Type 2 Consumption Forecast (2022-2028)

    • 8.2 United States Orexin Receptor Type 2 Consumption Forecast (2022-2028)

    • 8.3 Europe Orexin Receptor Type 2 Consumption Forecast (2022-2028)

    • 8.4 China Orexin Receptor Type 2 Consumption Forecast (2022-2028)

    • 8.5 Japan Orexin Receptor Type 2 Consumption Forecast (2022-2028)

    • 8.6 India Orexin Receptor Type 2 Consumption Forecast (2022-2028)

    • 8.7 South Korea Orexin Receptor Type 2 Consumption Forecast (2022-2028)

    9 Global Orexin Receptor Type 2 Market Outlook by Types and Applications to 2022

    • 9.1 Global Orexin Receptor Type 2 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global HTL-6641 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global MK-8133 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Lemborexant Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global OPN-021 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global YNT-185 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Orexin Receptor Type 2 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Insomnia Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Narcolepsy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Sleep Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Major Depressive Disorder Consumption and Growth Rate (2017-2022)

    10 Global Orexin Receptor Type 2 Market Outlook by Types and Applications to 2028

    • 10.1 Global Orexin Receptor Type 2 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global HTL-6641 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global MK-8133 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Lemborexant Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global OPN-021 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global YNT-185 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Orexin Receptor Type 2 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Insomnia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Narcolepsy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Sleep Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Major Depressive Disorder Consumption Forecast and Growth Rate (2022-2028)

    11 Global Orexin Receptor Type 2 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Orexin Receptor Type 2 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Orexin Receptor Type 2 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Orexin Receptor Type 2 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Orexin Receptor Type 2 Market Competitive Analysis

    • 14.1 OptiNose US Inc

      • 14.1.1 OptiNose US Inc Company Details

      • 14.1.2 OptiNose US Inc Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 OptiNose US Inc Orexin Receptor Type 2 Product and Service

    • 14.2 Johnson & Johnson

      • 14.2.1 Johnson & Johnson Company Details

      • 14.2.2 Johnson & Johnson Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Johnson & Johnson Orexin Receptor Type 2 Product and Service

    • 14.3 Heptares Therapeutics Ltd

      • 14.3.1 Heptares Therapeutics Ltd Company Details

      • 14.3.2 Heptares Therapeutics Ltd Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Heptares Therapeutics Ltd Orexin Receptor Type 2 Product and Service

    • 14.4 Actelion Pharmaceuticals Ltd

      • 14.4.1 Actelion Pharmaceuticals Ltd Company Details

      • 14.4.2 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Product and Service

    • 14.5 Yangtze River Pharmaceutical Group

      • 14.5.1 Yangtze River Pharmaceutical Group Company Details

      • 14.5.2 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Product and Service

    • 14.6 Merck & Co Inc

      • 14.6.1 Merck & Co Inc Company Details

      • 14.6.2 Merck & Co Inc Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck & Co Inc Orexin Receptor Type 2 Product and Service

    • 14.7 Idorsia Ltd

      • 14.7.1 Idorsia Ltd Company Details

      • 14.7.2 Idorsia Ltd Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Idorsia Ltd Orexin Receptor Type 2 Product and Service

    • 14.8 Evotec AG

      • 14.8.1 Evotec AG Company Details

      • 14.8.2 Evotec AG Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Evotec AG Orexin Receptor Type 2 Product and Service

    • 14.9 Eisai Co Ltd

      • 14.9.1 Eisai Co Ltd Company Details

      • 14.9.2 Eisai Co Ltd Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Eisai Co Ltd Orexin Receptor Type 2 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Orexin Receptor Type 2

    • Figure Orexin Receptor Type 2 Picture

    • Table Global Orexin Receptor Type 2 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Orexin Receptor Type 2 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Orexin Receptor Type 2 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Orexin Receptor Type 2 Consumption by Country (2017-2022)

    • Figure United States Orexin Receptor Type 2 Consumption and Growth Rate (2017-2022)

    • Table Europe Orexin Receptor Type 2 Consumption and Growth Rate (2017-2022)

    • Figure China Orexin Receptor Type 2 Consumption and Growth Rate (2017-2022)

    • Figure Japan Orexin Receptor Type 2 Consumption and Growth Rate (2017-2022)

    • Figure India Orexin Receptor Type 2 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Orexin Receptor Type 2 Consumption and Growth Rate (2017-2022)

    • Figure Global Orexin Receptor Type 2 Consumption Forecast by Country (2022-2028)

    • Figure United States Orexin Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Orexin Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Orexin Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Orexin Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Orexin Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Orexin Receptor Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HTL-6641 Consumption and Growth Rate (2017-2022)

    • Figure Global MK-8133 Consumption and Growth Rate (2017-2022)

    • Figure Global Lemborexant Consumption and Growth Rate (2017-2022)

    • Figure Global OPN-021 Consumption and Growth Rate (2017-2022)

    • Figure Global YNT-185 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Insomnia Consumption and Growth Rate (2017-2022)

    • Figure Global Narcolepsy Consumption and Growth Rate (2017-2022)

    • Figure Global Sleep Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Major Depressive Disorder Consumption and Growth Rate (2017-2022)

    • Figure Global HTL-6641 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MK-8133 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lemborexant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global OPN-021 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global YNT-185 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insomnia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Narcolepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sleep Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Major Depressive Disorder Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Orexin Receptor Type 2 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Orexin Receptor Type 2 Export by Region (Top 5 Countries) (2017-2028)

    • Table OptiNose US Inc (Foundation Year, Company Profile and etc.)

    • Table OptiNose US Inc Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table OptiNose US Inc Orexin Receptor Type 2 Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Orexin Receptor Type 2 Product and Service

    • Table Heptares Therapeutics Ltd (Foundation Year, Company Profile and etc.)

    • Table Heptares Therapeutics Ltd Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Heptares Therapeutics Ltd Orexin Receptor Type 2 Product and Service

    • Table Actelion Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)

    • Table Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actelion Pharmaceuticals Ltd Orexin Receptor Type 2 Product and Service

    • Table Yangtze River Pharmaceutical Group (Foundation Year, Company Profile and etc.)

    • Table Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Yangtze River Pharmaceutical Group Orexin Receptor Type 2 Product and Service

    • Table Merck & Co Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co Inc Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc Orexin Receptor Type 2 Product and Service

    • Table Idorsia Ltd (Foundation Year, Company Profile and etc.)

    • Table Idorsia Ltd Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Idorsia Ltd Orexin Receptor Type 2 Product and Service

    • Table Evotec AG (Foundation Year, Company Profile and etc.)

    • Table Evotec AG Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Evotec AG Orexin Receptor Type 2 Product and Service

    • Table Eisai Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Eisai Co Ltd Orexin Receptor Type 2 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Co Ltd Orexin Receptor Type 2 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.